Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection

Physiological Research

Volumn 59, Issue 3, 2010, Pages 379-384

  Skalicka B ^a   Malek I ^a   Kubanek M ^a   Vymetalova J ^a   Kautzner, J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Heart transplantation; Ongoing rejection; Recurrent rejection; Tacrolimus

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACUTE DISEASE; ADULT; ARTICLE; BIOPSY; DRUG EFFECT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; BIOPSY; CYCLOSPORINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77956222778     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BILLINGHAM ME, CARY NR, HAMMOND ME, KEMNITZ J, MARBOE C, MCCALLISTER HA, SNOVAR DC, WINTERS GL, ZERBE A: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. Heart Transplant 9: 587-593, 1990.
2. DE BONIS M, REYNOLDS L, BARROS J, MADDEN BP: Tacrolimus as a rescue immunosuppressant after heart transplantation. Eur J Cardiothorac Surg 19: 690-695, 2001.
3. DUFKOVÁ B, MÁLEK I, VYMĚTALOVÁ Y: Switching to tacrolimus in heart transplant recipients with recurrent rejection episodes. Cor Vasa 48: 421-425, 2006.
4. EBBS A, PAN F, WYNN C, ERICSON L, KOBAYASHI M, JIANG H: Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. Transpl Proc 34: 1378-1381, 2002.
5. ERICKSON LM, PAN F, EBBS A, KOBAYASHI M, JIANG H: Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. Transplantation 76: 582-588, 2003.
6. INGULLI E: Mechanism of cellular rejection in transplantation. Pediatr Nephrol 25: 61-74, 2010.
7. JIANG H, YANG XF, WYNN C, SORIANO R, KRISHNAN K, FUJIMURA T, KOBAYASHI M: IL-10: A tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. Transpl Proc 33: 510-513, 2001.
8. JIANG H, WYNN C, PAN F, EBBS A, ERICKSON L, KOBAYASHI M: Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhabit interleukin-10 production. Transplantation 73: 1808-1817, 2002.
9. MÁLEK I: Heart Transplantation, Cardiologist Point of View. Triton, Praha, 2004, p. 103.
10. ONSAGER DR, CANVER CC, JAHANIA MS, WELTER D, MICHALSKI M, HOFFMAN AM, MENTZER RM Jr, LOVE RB: Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. J Heart Lung Transplant 18: 448-455, 1999.
11. SCHREIBER SL, CRABTREE GR: The mechanism of action of cyclosporine A and FK506. Immunol Today 13: 136-142, 1992.
12. SHELDON S, POULTON K: HLA typing and its influence on organ transplantation. Methods Mol Biol 333: 157-174, 2006.
13. TAYLOR DO, EDWARDS LB, BOUCEK MM, TRULOCK EP, AURORA P, CHRISTIE J, DOBBELS F, RAHMEL AO, KECK BM, HERTZ MI: Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report - 2007. J Heart Lung Transplant 26: 769-781, 2007.
14. THOMSON AW, STARZL TE: New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev 130: 71-98, 1993.
15. VALANTINE H: Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23 (5 Suppl): S187-S193, 2004.
16. VYMĚTALOVÁ Y, MÁLEK I: Acute rejection after heart transplantation. Kardio Forum 3: 12-15, 2005.
17. YAMANI MH, STARLING RC, PELEGRIN D, PLATT L, MAJERCIK M, HOBBS RE, MCCARTHY P, YOUNG JB: Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. J Heart Lung Transplant 19: 337-342, 2000.